The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: A meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 7, 2011, Pages 1053-1060

  Zhou, Wen Bin ^a   Xue, Dan Qing ^a   Liu, Xiao An ^a   Ding, Qiang ^a   Wang, Shui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Benign breast disease; Breast cancer risk; Family history; Meta analysis

Indexed keywords

ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL LOBULAR HYPERPLASIA; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER CLASSIFICATION; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDLINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 85027945961     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-0979-z     Document Type: Review

References (35)

1. Bianchi SDTM, Simoncini R, Distante V, Russo A, Palli D (1992) Histological pattern of benign breast disease as a risk factor for invasive breast cancer. Cancer Detect Prev 16:17-19
2. Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL (2008) Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer 113(9):2415-2421. doi:10.1002/cncr.23873
3. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, Carter C, Hoover R (2001) Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12(2):103-110 (Pubitemid 32165267)
4. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128(3): 467-477
5. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2006) The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer 107(6):1240-1247. doi: 10.1002/cncr.22136 (Pubitemid 44452772)
6. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the nurses' health study. Cancer 109(2):180-187. doi:10.1002/cncr.22408 (Pubitemid 46106232)
7. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ III, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25(19):2671-2677. doi:10.1200/JCO.2006.09.0217 (Pubitemid 47123172)
8. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188. doi:0197-2456(86)90046-2
9. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146-151. doi:10.1056/ NEJM198501173120303 (Pubitemid 15192861)
10. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71(4):1258-1265 (Pubitemid 23054916)
11. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634 (Pubitemid 27387172)
12. Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer committee of the college of American pathologists. Arch Pathol Lab Med 122(12): 1053-1055 (Pubitemid 29009396)
13. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879-1886 (Pubitemid 20026073)
14. Griffin JL, Pearlman MD (2010) Breast cancer screening in women at average risk and high risk. Obstet Gynecol 116(6):1410-1421. doi:10.1097/AOG.0b013e3181fe714e
15. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ III, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229-237. doi:10.1056/NEJMoa044383 (Pubitemid 41058322)
16. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340(6):430-436. doi:10.1056/NEJM199902113400604 (Pubitemid 29084774)
17. Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE (2010) A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 21(6):821-828. doi:10.1007/s10552-010-9508-7
18. Kalache A (1981) Risk factors for breast cancer: a tabular summary of the epidemiological literature. Br J Surg 68(11):797-799
19. King TA, Scharfenberg JC, Smetherman DH, Farkas EA, Bolton JS, Fuhrman GM (2000) A better understanding of the term radial scar. Am J Surg 180(6):428-432. doi:S0002-9610(00)00506-7 (discussion 432-423)
20. Kuzma JF (1969) Carcinoma-in situ of the breast. J Fla Med Assoc 56(12):905-906
21. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826 (Pubitemid 27465551)
22. Liu X, Wang Z, Yu J, Lei G, Wang S (2010) Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a metaanalysis. Breast Cancer Res Treat 124(3):821-825. doi:10.1007/s10549-010-0910-3
23. London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267(7):941-944
24. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
25. Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6(5):297-301 (Pubitemid 27204018)
26. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 69(6):1408-1414
27. Meissner HI, Klabunde CN, Han PK, Benard VB, Breen N (2011) Breast cancer screening beliefs, recommendations and practices: primary care physicians in the united states. Cancer. doi:10.1002/cncr.25873
28. Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698-2708
29. Patterson JA, Scott M, Anderson N, Kirk SJ (2004) Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 30(10): 1065-1068. doi:10.1016/j.ejso.2004.08.004 (Pubitemid 40267810)
30. Ready K, Arun B (2010) Clinical assessment of breast cancer risk based on family history. J Natl Compr Canc Netw 8(10):1148-1155. doi:8/10/1148
31. Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EM, Foster CS (2002) Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 26(4):421-430 (Pubitemid 34280114)
32. Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton LJ III, Liu ET, Conway K (2000) HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 18(2):267-274 (Pubitemid 30056414)
33. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96(8):616-620 (Pubitemid 38584985)
34. Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13(2):115-121. doi:10.1111/j.1524-4741.2007.00388.x (Pubitemid 46280598)
35. Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, Shah V, Savera A, Wolman SR (2009) Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118(1):1-7. doi:10.1007/s10549- 008-0198-8